SCHEMBL25001454

SCHEMBL25001454

COCCN1CCN(c2cc(OC)c(Nc3ncc(Br)c(Nc4ccc5nccnc5c4C4(C)CC(=O)C4C)n3)cc2-c2cnn(C)c2)CC1

nearest known ligand 0.49

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ EGFR P00533 20/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25820625 0.87 EGFR (0.62) EGFR
SCHEMBL25827271 0.87 EGFR (0.52) EGFR
SCHEMBL25001456 0.86 EGFR (0.49) EGFR
SCHEMBL25821109 0.86 EGFR (0.49) EGFR
SCHEMBL25001563 0.83 EGFR (0.59) EGFR
SCHEMBL25828328 0.82 EGFR (0.59) EGFR
SCHEMBL25001564 0.82 EGFR (0.47) EGFR
SCHEMBL25001419 0.82 EGFR (0.62) EGFR
SCHEMBL25820665 0.82 EGFR (0.62) EGFR
SCHEMBL25001935 0.82 EGFR (0.64) EGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4129996-A1 NOVEL AMINOPYRIMIDINE EGFR INHIBITOR QILU PHARMACEUTICAL CO., LTD. (CN) 2023-02-08 — — EP disclosed
Send feedback